NVRNYSEOperative BuildersFiscal year ends December 31
NVR INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$5828.00−91.82 (-1.55%)
Close on Oct 19, 2026
- Market cap
- $16.41B
- P/E (TTM)
- 15.1
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
89.8%
2M of 3M shares
Institutional holders
687
88 new, 49 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
3 buys · 4 sales
Net sold $8.43M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 247,270 | 8.90% | 13G (passive) amendment | Mar 31, 2026 |
| Vanguard Capital Management | 205,105 | 7.38% | 13G (passive) | Mar 31, 2026 |
| Capital Research Global Investors | 162,965 | 5.90% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NVR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 294,174 | 11.04% | $2.00B | +12,219 | 0.03% |
| Vanguard Capital Management LLC | 174,915 | 6.56% | $1.19B | −2,710 | 0.03% |
| Capital Research Global Investors | 163,844 | 6.15% | $1.12B | +879 | 0.16% |
| State Street Corp | 128,768 | 4.83% | $877.35M | +1,172 | 0.03% |
| Vanguard Portfolio Management LLC | 113,182 | 4.25% | $771.15M | −6,115 | 0.03% |
| Geode Capital Management, LLC | 73,735 | 2.77% | $500.44M | +38 | 0.03% |
| Boston Partners | 60,776 | 2.28% | $414.00M | +2,793 | 0.37% |
| Principal Financial Group Inc | 58,535 | 2.20% | $398.82M | +290 | 0.20% |
| Aqr Capital Management LLC | 49,101 | 1.84% | $334.55M | +40,237 | 0.12% |
| Invesco Ltd. | 46,803 | 1.76% | $318.89M | +3,806 | 0.03% |
| Capital World Investors | 40,876 | 1.53% | $278.50M | +115 | 0.03% |
| Norges Bank | 38,888 | 1.46% | $264.96M | New | 0.03% |
| Dimensional Fund Advisors LP | 37,508 | 1.41% | $255.56M | −2,646 | 0.05% |
| Morgan Stanley | 31,899 | 1.20% | $217.35M | −282 | 0.01% |
| Goldman Sachs Group Inc | 30,477 | 1.14% | $207.65M | +12,763 | 0.02% |
| Wellington Management Group Llp | 30,426 | 1.14% | $207.30M | −769 | 0.04% |
| Caisse De Depot Et Placement Du Quebec | 28,490 | 1.07% | $194.11M | +1,224 | 0.28% |
| Smead Capital Management, Inc. | 28,248 | 1.06% | $192.47M | +6,710 | 4.13% |
| Nuveen, LLC | 26,275 | 0.99% | $179.02M | −3,077 | 0.04% |
| First Trust Advisors LP | 25,678 | 0.96% | $174.96M | +1,260 | 0.10% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 687 | 2M | 89.8% | 88 / 245 | 236 / 49 | 0M | 0M |
| Q1 2026 | 657 | 2M | 87.0% | 60 / 223 | 237 / 80 | 0M | 0M |
| Q4 2025 | 687 | 2M | 92.4% | 85 / 215 | 246 / 60 | 0M | 0M |
| Q3 2025 | 678 | 3M | 93.9% | 69 / 211 | 236 / 41 | 0M | 0M |
| Q2 2025 | 654 | 3M | 93.9% | 72 / 220 | 229 / 80 | 0M | 0M |
| Q1 2025 | 676 | 3M | 95.9% | 68 / 230 | 222 / 83 | 0M | 0M |
| Q4 2024 | 701 | 3M | 96.4% | 86 / 200 | 246 / 78 | 0M | 1M |
| Q3 2024 | 703 | 3M | 100.0% | 78 / 201 | 260 / 39 | 1M | 0M |
| Q2 2024 | 672 | 3M | 97.1% | 50 / 208 | 237 / 44 | 0M | 0M |
| Q1 2024 | 675 | 3M | 100.0% | 73 / 200 | 243 / 42 | 0M | 0M |
| Q4 2023 | 647 | 3M | 100.0% | 98 / 174 | 256 / 35 | 0M | 0M |
| Q3 2023 | 596 | 3M | 100.0% | 49 / 208 | 210 / 50 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of NVR | Value | % of fund | As of |
|---|---|---|---|---|---|
| Growth Fund of America | 116,169 | 4.36% | $709.19M | 0.20% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 81,373 | 3.05% | $554.43M | 0.02% | Jun 30, 2026 |
| AMCAP Fund | 79,357 | 2.98% | $484.46M | 0.50% | May 31, 2026 |
| Vanguard 500 Index Fund | 72,883 | 2.73% | $496.58M | 0.03% | Jun 30, 2026 |
| MidCap Fund | 45,958 | 1.72% | $282.51M | 1.22% | Jul 31, 2026 |
| iShares Core S&P 500 ETF | 37,702 | 1.41% | $256.88M | 0.03% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 35,755 | 1.34% | $218.28M | 0.03% | May 31, 2026 |
| Disciplined Value Mid Cap Fund | 31,917 | 1.20% | $217.46M | 0.94% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF | 29,689 | 1.11% | $182.50M | 0.19% | Jul 31, 2026 |
| Vanguard Small-Cap Index Fund | 29,365 | 1.10% | $200.08M | 0.11% | Jun 30, 2026 |
| Vanguard Mid-Cap Index Fund | 27,788 | 1.04% | $189.33M | 0.08% | Jun 30, 2026 |
| iShares MSCI USA Quality Factor ETF | 26,598 | 1.00% | $163.50M | 0.35% | Jul 31, 2026 |
| iShares U.S. Home Construction ETF | 25,674 | 0.96% | $174.93M | 6.72% | Jun 30, 2026 |
| Smead Value Fund | 23,445 | 0.88% | $143.13M | 3.68% | May 29, 2026 |
| First Trust Capital Strength ETF | 22,000 | 0.83% | $149.89M | 1.96% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Paul C. Saville | Executive Chairman | 114,967 | 4.31% | May 18, 2026 |
| Matthew B. Kelpy | VP, Chief Accounting Officer | 767 | 0.03% | May 18, 2026 |
| Daniel David Malzahn | Chief Financial Officer | 15,202 | 0.57% | May 18, 2026 |
| Eugene James Bredow | Chief Executive Officer | 3,034 | 0.11% | May 18, 2026 |
| George Oliver | Director | 63 | 0.00% | Aug 11, 2026 |
| Melquiades R. Martinez | Director | 162 | 0.01% | Jul 31, 2026 |
| Susan Williamson Ross | Director | 624 | 0.02% | May 29, 2026 |
| Michael J. DeVito | Director | 25 | 0.00% | May 18, 2026 |
| David A. Preiser | Director | 204 | 0.01% | May 18, 2026 |
| William Grady Rosier | Director | 1,592 | 0.06% | May 18, 2026 |
| Sallie B. Bailey | Director | 100 | 0.00% | May 18, 2026 |
| Charles Elliott Andrews | Director | 774 | 0.03% | May 18, 2026 |
| Alfred E. Festa | Director | 173 | 0.01% | May 18, 2026 |
| Alexandra A. Jung | Director | 75 | 0.00% | May 18, 2026 |
| Thomas D. Eckert | Director | 550 | 0.02% | Feb 13, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| George Oliver Director | Aug 7, 2026 | Buy | +63 | $6431.51 | $405.19K | 63 |
| Melquiades R. Martinez Director | Jul 30, 2026 | Gift | −29 | – | – | 162 |
| Susan Williamson Ross Director | May 29, 2026 | Option exercise | +238 | $1700.00 | $404.60K | 624 |
| Eugene James Bredow Chief Executive Officer | May 14, 2026 | Discretionary | +60 | $5776.15 | $346.57K | 140 |
| Eugene James Bredow Chief Executive Officer | May 6, 2026 | Discretionary | +80 | $6262.53 | $501.00K | 80 |
| Michael J. DeVito Director | Apr 24, 2026 | Buy | +11 | $6699.50 | $73.69K | 25 |
| Charles Elliott Andrews Director | Feb 20, 2026 | Gift | −5 | – | – | 774 |
| Susan Williamson Ross Director | Feb 13, 2026 | Option exercise | +200 | $1700.00 | $340.00K | 586 |
| Susan Williamson Ross Director | Feb 13, 2026 | Sale | −200 | $7922.06 | $1.58M | 386 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Feb 10, 2026 | Option exercise | +500 | $4475.53 | $2.24M | 708 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Feb 10, 2026 | Sale | −500 | $8100.00 | $4.05M | 208 |
| Susan Williamson Ross Director | Feb 5, 2026 | Option exercise | +200 | $1700.00 | $340.00K | 586 |
| Susan Williamson Ross Director | Feb 5, 2026 | Sale | −200 | $8091.62 | $1.62M | 386 |
| Susan Williamson Ross Director | Feb 4, 2026 | Sale | −220 | $8000.00 | $1.76M | 386 |
| Susan Williamson Ross Director | Feb 4, 2026 | Option exercise | +220 | $1700.00 | $374.00K | 606 |
| Charles Elliott Andrews Director | Dec 16, 2025 | Gift | −50 | – | – | 779 |
| Daniel David Malzahn Chief Financial Officer | Dec 15, 2025 | Gift | −3 | – | – | 13,793 |
| David A. Preiser Director | Dec 12, 2025 | Gift | −35 | – | – | 204 |
| Michael J. DeVito Director | Nov 3, 2025 | Buy | +14 | $7068.05 | $98.95K | 14 |
| Alexandra A. Jung Director | Aug 26, 2025 | Sale | −200 | $8082.44 | $1.62M | 75 |
| Alexandra A. Jung Director | Aug 26, 2025 | Option exercise | +200 | $2450.00 | $490.00K | 275 |
| Alexandra A. Jung Director | Aug 22, 2025 | Sale | −50 | $8231.74 | $411.59K | 75 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Aug 13, 2025 | Option exercise | +600 | $2843.17 | $1.71M | 808 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Aug 13, 2025 | Sale | −600 | $8100.00 | $4.86M | 208 |
| Susan Williamson Ross Director | Aug 4, 2025 | Option exercise | +125 | $1700.00 | $212.50K | 511 |
| Susan Williamson Ross Director | Aug 4, 2025 | Sale | −125 | $7850.28 | $981.29K | 386 |
| Daniel David Malzahn Chief Financial Officer | Aug 1, 2025 | Gift | −33 | – | – | 13,796 |
| Charles Elliott Andrews Director | Feb 18, 2025 | Gift | −3 | – | – | 829 |
| Thomas D. Eckert Director | Feb 11, 2025 | Sale | −500 | $7529.89 | $3.76M | 550 |
| Thomas D. Eckert Director | Feb 10, 2025 | Sale | −143 | $7515.60 | $1.07M | 1,050 |
| Thomas D. Eckert Director | Feb 10, 2025 | Option exercise | +143 | $4475.53 | $640.00K | 1,193 |
| Charles Elliott Andrews Director | Dec 10, 2024 | Gift | −25 | – | – | 832 |
| William Grady Rosier Director | Nov 25, 2024 | Gift | −109 | – | – | 1,592 |
| David A. Preiser Director | Nov 8, 2024 | Sale | −250 | $9302.64 | $2.33M | 239 |
| David A. Preiser Director | Nov 8, 2024 | Option exercise | +250 | $3022.99 | $755.75K | 489 |
| Thomas D. Eckert Director | Nov 7, 2024 | Option exercise | +1,000 | $3022.99 | $3.02M | 2,050 |
| Thomas D. Eckert Director | Nov 7, 2024 | Sale | −1,000 | $9216.32 | $9.22M | 1,050 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Nov 5, 2024 | Option exercise | +400 | $2843.17 | $1.14M | 608 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Nov 5, 2024 | Sale | −400 | $9450.00 | $3.78M | 208 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Oct 25, 2024 | Gift | −22 | – | – | 208 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Oct 24, 2024 | Option exercise | +125 | $2843.17 | $355.40K | 355 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Oct 24, 2024 | Sale | −125 | $9507.30 | $1.19M | 230 |
| Thomas D. Eckert Director | Sep 9, 2024 | Gift | −50 | – | – | 1,050 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Aug 9, 2024 | Sale | −200 | $8500.00 | $1.70M | 230 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Aug 9, 2024 | Option exercise | +200 | $2843.17 | $568.63K | 430 |
| Melquiades R. Martinez Director | Aug 8, 2024 | Sale | −125 | $8372.77 | $1.05M | 191 |
| Melquiades R. Martinez Director | Aug 8, 2024 | Option exercise | +125 | $3022.99 | $377.87K | 316 |
| Alfred E. Festa Director | Jul 29, 2024 | Sale | −148 | $8585.95 | $1.27M | 173 |
| Susan Williamson Ross Director | Jul 26, 2024 | Gift | −5 | – | – | 386 |
| Susan Williamson Ross Director | Jul 26, 2024 | Sale | −125 | $8505.91 | $1.06M | 391 |
| Susan Williamson Ross Director | Jul 26, 2024 | Option exercise | +125 | $1700.00 | $212.50K | 516 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Jul 26, 2024 | Option exercise | +175 | $2843.17 | $497.55K | 405 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Jul 26, 2024 | Sale | −175 | $8650.00 | $1.51M | 230 |
| Daniel David Malzahn Chief Financial Officer | Jul 25, 2024 | Gift | −30 | – | – | 13,829 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Jul 25, 2024 | Sale | −500 | $8500.00 | $4.25M | 230 |
| Matthew B. Kelpy VP, Chief Accounting Officer | Jul 25, 2024 | Option exercise | +500 | $1934.97 | $967.49K | 730 |
| Paul C. Saville Executive Chairman | May 9, 2024 | Option exercise | +300 | $1094.22 | $328.27K | 107,160 |
| Paul C. Saville Executive Chairman | May 9, 2024 | Sale | −300 | $7670.42 | $2.30M | 106,860 |
| William Grady Rosier Director | May 8, 2024 | Sale | −600 | $7665.63 | $4.60M | 1,701 |
| Matthew B. Kelpy VP, Chief Accounting Officer | May 7, 2024 | Option exercise | +200 | $1934.97 | $386.99K | 430 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Susan Williamson Ross Director | Feb 13, 2026 | 200 | $1.62M | Feb 13, 2026 | Stock Options |
| B. Kelpy Matthew Officer | Feb 10, 2026 | 500 | $3.94M | Feb 10, 2026 | Stock Options |
| Susan Williamson Ross Director | Feb 5, 2026 | 200 | $1.61M | Feb 5, 2026 | Stock Options |
| Susan Williamson Ross Director | Feb 4, 2026 | 220 | $1.71M | Feb 4, 2026 | Stock Options |
| A. Jung Alexandra Director | Aug 26, 2025 | 200 | $1.63M | Aug 26, 2025 | Stock Options |
| A. Jung Rev Tst U/A 06/29/06 Alexandra Director | Aug 22, 2025 | 50 | $411.59K | Aug 22, 2025 | Open Market |
| Matthew B. Kelpy Officer | Aug 13, 2025 | 600 | $4.78M | Aug 13, 2025 | Stock Options |
| Susan Williamson Ross Director | Aug 4, 2025 | 125 | $970.09K | Aug 4, 2025 | Stock Options |
| Thomas D. Eckert Director | Feb 11, 2025 | 500 | $3.76M | Feb 11, 2025 | Open MKT Purchase |
| Thomas D. Eckert Director | Feb 10, 2025 | 143 | $1.08M | Feb 10, 2025 | Stock Options |
| David A. Preiser Director | Nov 8, 2024 | 250 | $2.31M | Nov 8, 2024 | Stock Options |
| Thomas D. Eckert Director | Nov 7, 2024 | 1,000 | $9.20M | Nov 7, 2024 | Stock Options |
| Matthew B. Kelpy Officer | Nov 5, 2024 | 1,000 | $9.26M | Nov 5, 2024 | Employee Stock Options |
| Melquiades R. Martinez Director | Aug 8, 2024 | 125 | $1.03M | Aug 8, 2024 | Stock Options |
| Alfred E. Festa Director | Jul 29, 2024 | 148 | $1.27M | Jul 29, 2024 | Restricted Stock Units |